Please login to the form below

CytomX

This page shows the latest CytomX news and features for those working in and with pharma, biotech and healthcare.

Amgen pledges $1.5bn for CytomX preclinical cancer drugs

In an unusual development, CytomX also gets a stake in an unnamed T-cell engaging bispecific developed at Amgen. ... Shares in US clinical stage biopharmaceutical company CytomX leaped more than a third on the latest deal.

Latest news

BMS taps F-star Alpha for immuno-oncology drug

MD Anderson Cancer Centre in the US, as well as earlier collaborations with InCyte and CytoMx.
Pfizer signs $635m deal with CytomX for cancer ADCs

CytomX has developed an ADC platform called Probody that it says can create ADCs that are safer and more effective than current technologies. ... The mask is designed to be removed in the presence of an enzyme that is found only in diseased cells, says

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Deal Watch March 2017

BMS has expanded its 2014 agreement with CytomX Therapeutics to access up to eight further targets in oncology and other fields, using CytomX’s Probody platform. ... 650. CytomX Therapeutics. BMS. Strategic collaboration. Probody platform to enhance
Deal Watch April 2016

CytomX leads. Argenx undertakes R&D until IND, AbbVie thereafter it option exercised. ... Zymeworks, like CytomX, have multiple Big Pharma partners including Merck &Co and Lilly.
Deal Watch table for May 2014

CytomX / BMS. Development and commercialisation licence. Selective monoclonal antibodies (“Probodies”) for up to 4 oncology targets.
Pharma deals during May 2014

BMS also entered into a platform deal with CytomX for so-called “Probodies,” monoclonal antibodies that are selectively activated within the cancer microenvironment.
Deal Watch table for June 2013

818. CytomX / Pfizer. Collaboration and exclusive licence to selected PDCs.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

CytomX appoints Rachel Humphrey chief medical officer

Former VP of Eli Lilly and AstraZeneca joins the company. CytomX Therapeutics has appointed Dr Rachel Humphrey as chief medical officer. ... She said: “Since joining the CytomX board of directors in March, I have been able to see at first-hand the
CytomX makes senior changes following Pfizer deal

CytomX Therapeutics has boosted both its senior science and business teams following a major antibody deal with Pfizer. ... His new colleague Ray joined CytomX in 2011 and was instrumental in brokering the agreement with Pfizer.

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Account Director, Medical Education: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Digital Account Director: Salary TBC

Senior Medical Writer: Great salary and benefits

Project Manager/ Account Manager: Salary TBC

Senior Medical Writer: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Medical Writer: Up to £50, 000 with Benefits

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

The importance of co-creation with patients: Overcoming the barriers...
Three billboards on the road to multichannel: Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence: Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....